查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701244

美國CT 和 MRI顯影劑市場規模、佔有率、趨勢分析報告（按模式、產品、應用、給藥途徑、最終用途、細分市場預測），2025-2030 年

U.S. CT And MRI Contrast Media Market Size, Share & Trends Analysis Report By Modality, By Product, By Application, By Route Of Administration, By End-use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

美國CT 和 MRI顯影劑市場的成長和趨勢：

根據 Grand View Research 的新報告，美國CT 和 MRI顯影劑市場規模預計到 2030 年將達到 31.7 億美元，2025 年至 2030 年的複合年成長率為 7.23%。

這種成長是由市場參與企業之間日益激烈的競爭、研究活動的活性化以及臨床試驗和研究的增加所推動的。此外，行業參與者對產品核可的日益關注預計將推動未來幾年的市場成長。

例如，2023年6月，拜耳公司的碘基顯影劑Ultravist獲得美國食品藥物管理局的核准，可用於造影乳房X光攝影。 Ultravist 也適用於身體和頭部的造影CT 檢查，以評估成人和 2 歲及以上兒童患者中的非腫瘤性和腫瘤性病變。因此，顯影劑未來幾年 FDA 對 CT 和 MRI顯影劑的核准增加將推動美國市場的成長。

目前，有多項臨床研究正在檢驗顯影劑在多種慢性疾病的各種 CT 和 MRI 檢查中的有效性和效用。例如，麻州大學伍斯特分校正在舉辦一項臨床試驗，已招募 258 名參與者。這項臨床試驗正在比較兩種大環钆基顯影劑，钆布醇（Gadavist）和钆葡甲胺（Dotarem），用於診斷乳房疾病。該試驗預計於2026年3月完成。此外，埃默里大學將於2024年7月開始針對前列腺癌患者進行標靶磁振造影顯影劑的試驗。如果這些臨床試驗取得正面成果，預計美國對CT和MRI顯影劑的需求將會增加，從而促進美國市場的成長。

美國CT 和 MRI顯影劑市場報告重點

  • 按方式分類，X光/電腦斷層掃描領域在 2024 年佔據了市場主導地位。然而，預計磁振造影(MRI) 領域將成長最快，預測期內的複合年成長率為 8.52%。
  • 從產品角度來看，碘顯影劑領域在 2024 年佔據了美國CT 和 MRI顯影劑市場的主導地位。另一方面，預計钆基顯影劑領域將在未來幾年內實現最快成長。
  • 根據應用，神經系統疾病領域在 2024 年佔據市場最大收益佔有率，約 28.23%。相較之下，心血管疾病領域預計在預測期內以最高的複合年成長率成長。
  • 根據給藥途徑，預計靜脈給藥部分將在 2024 年佔據美國CT 和 MRI顯影劑市場的最大收益佔有率，約為 52.96%。由於美國市場上產品種類繁多，預計該部分在預測期內也將以最高的複合年成長率成長。
  • 根據最終用途，醫院部門佔據市場主導地位，佔 2024 年收入佔有率的 59.92%。預計該部門在預測期內成長最快。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國CT 和 MRI顯影劑市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國CT與MRI顯影劑市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國CT 和 MRI顯影劑市場：產品評估和趨勢分析

  • 定義和範圍
  • 2024年及2030年的市場佔有率
  • 細分儀表板
  • 美國CT 和 MRI顯影劑市場展望
  • 2018年至2030年市場規模、預測及趨勢分析
    • 钆顯影劑
    • 碘顯影劑

第5章美國CT 和 MRI顯影劑市場：模態估計和趨勢分析

  • 定義和範圍
  • 2024年及2030年的市場佔有率
  • 細分儀表板
  • 美國CT 和 MRI顯影劑市場展望
  • 2018年至2030年市場規模、預測及趨勢分析
    • 磁振造影
    • X光/電腦斷層掃描

第6章美國CT和MRI顯影劑市場：應用評估和趨勢分析

  • 定義和範圍
  • 2024年及2030年的市場佔有率
  • 細分儀表板
  • 美國CT 和 MRI顯影劑市場展望
  • 2018年至2030年市場規模、預測及趨勢分析
    • 心血管疾病
    • 神經系統疾病
    • 胃腸道疾病
    • 癌症
    • 腎臟疾病
    • 肌肉骨骼疾病
    • 其他

第7章美國CT和MRI顯影劑市場：給藥途徑估計和趨勢分析

  • 定義和範圍
  • 2024年及2030年的市場佔有率
  • 細分儀表板
  • 美國CT 和 MRI顯影劑市場展望
  • 2018年至2030年市場規模、預測及趨勢分析
    • 靜脈
    • 口服顯影劑
    • 直腸

第8章美國CT和MRI顯影劑市場：最終用途估計和趨勢分析

  • 定義和範圍
  • 2024年及2030年的市場佔有率
  • 細分儀表板
  • 美國CT 和 MRI顯影劑市場展望
  • 2018年至2030年市場規模、預測及趨勢分析
    • 醫院
    • 診斷影像中心
    • 其他

第9章競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • 主要客戶
    • 2024年主要企業市場佔有率分析
    • Bayer
    • GE Healthcare
    • Guerbet
    • Bracco Diagnostics Inc
    • Fresenius Kabi
Product Code: GVR-4-68040-533-6

U.S. CT and MRI Contrast Media Market Growth & Trends:

The U.S. CT and MRI contrast media market size is anticipated to reach USD 3.17 billion by 2030, expanding at a CAGR of 7.23% from 2025 to 2030, based on a new report by Grand View Research, Inc. This growth can be attributed to the growing competition among the market participants, rising research activities, and the increasing number of clinical trials and studies. Moreover, the rising focus of industry players on product approvals is anticipated to propel market growth in the coming years.

For instance, in June 2023, Ultravist, an iodine-based contrast agent from Bayer, received approval from the U.S. Food and Drug Administration for contrast-enhanced mammography. Ultravist is also indicated for contrast computed tomography of the body and head to evaluate non-neoplastic and neoplastic lesions in adults and pediatric patients aged 2 years and older. Thus, increasing FDA approvals of CT and MRI contrast agents is anticipated to propel the U.S. market growth in the coming years.

Currently, multiple clinical studies are examining the efficacy and utility of contrast agents in various CT and MRI examinations used for several chronic conditions. For instance, the University of Massachusetts in Worcester sponsors a clinical trial that has enrolled 258 participants. This trial compares two macrocyclic gadolinium-based contrast agents, gadobutrol (Gadavist) and gadoterate meglumine (Dotarem), for diagnosing breast diseases. The study is expected to be completed by March 2026. In addition, Emory University has been conducting a study since July 2024 to evaluate a targeted magnetic resonance imaging contrast agent in prostate cancer patients. Positive findings from these clinical studies are anticipated to increase the demand for CT and MRI contrast media in the U.S., contributing to the U.S. market growth.

U.S. CT And MRI Contrast Media Market Report Highlights:

  • Based on modality, in 2024, the x-ray/ computed tomography segment dominated the market. However, the magnetic resonance imaging (MRI) segment is anticipated to grow fastest, with a CAGR of 8.52% over the forecast period.
  • On the basis of product, the iodinated contrast media segment dominated the U.S. CT and MRI contrast media market in 2024. On the other hand, the gadolinium-based contrast media segment is anticipated to grow fastest in the coming years.
  • Based on application, the neurological disorders segment held the largest revenue share of around 28.23% in the market in 2024. In contrast, the cardiovascular disorders segment is expected to grow fastest, with the highest CAGR over the forecast period.
  • On the basis of route of administration, the intravenous segment held the largest revenue share, around 52.96%, in the U.S. CT and MRI contrast media market in 2024. This segment is also expected to grow fastest, with the highest CAGR over the forecast period due to the availability of a wide range of products in the U.S. market.
  • On the basis of the end use, the hospital segment dominated the market and accounted for a revenue share of 59.92% in 2024. This segment is also expected to grow fastest over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Modality outlook
    • 2.2.3. Application outlook
    • 2.2.4. Route of administration outlook
    • 2.2.5. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. CT and MRI Contrast Media Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Increasing demand for medical imaging
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Side effects and potential complications associated with the use of CT MRI and contrast media
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Increasing number of clinical trials
      • 3.2.3.2. Rising research activities
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Product recalls
  • 3.3. U.S. CT and MRI Contrast Media Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. CT and MRI Contrast Media Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Product Market Share, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. U.S. CT and MRI Contrast Media Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Gadolinium-based Contrast Media
      • 4.5.1.1. Gadolinium-based contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Iodinated Contrast Media
      • 4.5.2.1. Iodinated contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. U.S. CT and MRI Contrast Media Market: Modality Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Modality Market Share, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. U.S. CT and MRI Contrast Media Market by Modality Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Magnetic Resonance Imaging
      • 5.5.1.1. Magnetic resonance imaging market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.2. Elucirem/Vueway
        • 5.5.1.2.1. Elucirem/Vueway market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.3. Dotarem
        • 5.5.1.3.1. Dotarem market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.4. ProHance
        • 5.5.1.4.1. ProHance market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.5. MultiHance
        • 5.5.1.5.1. MultiHance market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.6. Gadovist
        • 5.5.1.6.1. Gadovist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.7. Eovist / Primovist
        • 5.5.1.7.1. Eovist / Primovist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.8. Clariscan
        • 5.5.1.8.1. Clariscan market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.9. Other Generics
        • 5.5.1.9.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. X-ray/Computed Tomography
      • 5.5.2.1. X-ray/computed tomography market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.2. Optiray
        • 5.5.2.2.1. Optiray market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.3. ISOVUE
        • 5.5.2.3.1. ISOVUE market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.4. Ultravist
        • 5.5.2.4.1. Ultravist market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.5. Omnipaque
        • 5.5.2.5.1. Omnipaque market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.6. Visipaque
        • 5.5.2.6.1. Visipaque market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.7. Other Generics
        • 5.5.2.7.1. Other generics market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. CT and MRI Contrast Media Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Application Market Share, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. U.S. CT and MRI Contrast Media Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Cardiovascular Disorders
      • 6.5.1.1. Cardiovascular disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Neurological Disorders
      • 6.5.2.1. Neurological disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Gastrointestinal Disorders
      • 6.5.3.1. Gastrointestinal disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Cancer
      • 6.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Nephrological Disorders
      • 6.5.5.1. Nephrological disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.6. Musculoskeletal Disorders
      • 6.5.6.1. Musculoskeletal disorders market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.7. Others
      • 6.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. U.S. CT and MRI Contrast Media Market: Route of Administration Estimates & Trend Analysis

  • 7.1. Definitions and Scope
  • 7.2. Route of Administration Market Share, 2024 & 2030
  • 7.3. Segment Dashboard
  • 7.4. U.S. CT and MRI Contrast Media Market by Route of Administration Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Intravenous
      • 7.5.1.1. Intravenous contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.2. Oral Contrast Media
      • 7.5.2.1. Oral contrast media market estimates and forecast 2018 to 2030 (USD Million)
    • 7.5.3. Rectal
      • 7.5.3.1. Rectal contrast media market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. U.S. CT and MRI Contrast Media Market: End Use Estimates & Trend Analysis

  • 8.1. Definitions and Scope
  • 8.2. End Use Market Share, 2024 & 2030
  • 8.3. Segment Dashboard
  • 8.4. U.S. CT and MRI Contrast Media Market by End Use Outlook
  • 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.5.1. Hospitals
      • 8.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 8.5.2. Diagnostic Imaging Centers
      • 8.5.2.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
    • 8.5.3. Others
      • 8.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2024
    • 9.3.4. Bayer
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. GE Healthcare
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Guerbet
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Bracco Diagnostics Inc
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Fresenius Kabi
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. U.S. CT and MRI contrast media market, by modality 2018 - 2030 (USD Million)
  • Table 4. U.S. CT and MRI contrast media market, by product 2018 - 2030 (USD Million)
  • Table 5. U.S. CT and MRI contrast media market, by application, 2018 - 2030 (USD Million)
  • Table 6. U.S. CT and MRI contrast media market, by end-use 2018 - 2030 (USD Million)
  • Table 7. U.S. CT and MRI contrast media market, by route of administration, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. CT and MRI contrast media market: Market snapshot
  • Fig. 9 U.S. CT and MRI contrast media market: Market segmentation
  • Fig. 10 U.S. CT and MRI contrast media market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 U.S. CT and MRI contrast media market driver impact
  • Fig. 14 U.S. CT and MRI contrast media market restraint impact
  • Fig. 15 U.S. CT and MRI contrast media market porter's five forces analysis
  • Fig. 16 U.S. CT and MRI contrast media market PESTEL analysis
  • Fig. 17 U.S. CT and MRI contrast media market segment dashboard
  • Fig. 18 U.S. CT and MRI contrast media market: Product movement Analysis
  • Fig. 19 Gadolinium-based contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Iodinated contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. CT and MRI contrast media market: Modality movement Analysis
  • Fig. 22 Magnetic resonance imaging market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 X-ray/computed tomography market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. CT and MRI contrast media market: Application movement Analysis
  • Fig. 25 Cardiovascular disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Gastrointestinal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Nephrological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Musculoskeletal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. CT and MRI contrast media market: Route of administration movement Analysis
  • Fig. 32 Intravenous market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Oral contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Rectal contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. CT and MRI contrast media market: End use movement Analysis
  • Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Diagnostic imaging centers contrast media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Others market estimates and forecast, 2018 - 2030 (USD Million)